Combination therapy for disseminated strongyloidiasis with associated vancomycin-resistant, linezolid-intermediate Enterococcus faecium meningitis: A case report.
J Clin Pharm Ther
; 47(1): 121-124, 2022 Jan.
Article
em En
| MEDLINE
| ID: mdl-34075617
ABSTRACT
WHAT IS KNOWN AND OBJECTIVE:
The rhabditid nematode Strongyloides stercoralis is the major causative agent of disseminated strongyloidiasis (DS). In rare cases, DS has caused enterococcal meningitis. If DS-associated vancomycin-resistant Enterococcus faecium (VRE) meningitis is suspected, combination antibiotic therapy should be considered. CASESUMMARY:
We present a case of a 61-year-old male who developed DS associated with vancomycin-resistant and linezolid-intermediate E. faecium meningitis after receiving corticosteroids. The VRE meningitis was treated with high-dose daptomycin 12 mg/kg, linezolid, tigecycline and quinupristin/dalfopristin. Despite negative cultures, the patient expired. WHAT IS NEW ANDCONCLUSION:
In patients with DS-associated VRE meningitis, early use of combination therapy may be warranted to improve patient outcomes.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Estrongiloidíase
/
Meningites Bacterianas
/
Infecções por Bactérias Gram-Positivas
/
Farmacorresistência Bacteriana Múltipla
/
Antibacterianos
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article